The Clinical Group’s M&A Healthcare Advisory services guide clinical organizations through complex transactions, ensuring seamless integration and value maximization. With deep expertise in healthcare dynamics, we support buyers, sellers, and investors from due diligence to post-merger synergy realization.
- Strategic Deal Sourcing: Identify high-potential targets or buyers aligned with your clinical portfolio, focusing on geographic expansion, service line diversification, and market synergies.
- Valuation and Financial Modeling: Perform rigorous DCF, comparable company, and precedent transaction analyses tailored to healthcare metrics like patient volume and reimbursement rates.
- Due Diligence Expertise: Conduct clinical, operational, and compliance reviews to uncover risks in quality metrics, payer contracts, and regulatory exposures.
- Integration Planning: Develop 100-day post-close roadmaps for harmonizing clinical protocols, IT systems, and cultures to capture 80%+ of projected synergies.
- Regulatory Navigation: Advise on Stark Law, Anti-Kickback Statute, and FTC/HHS approvals to expedite deal timelines and avoid pitfalls.
- Exit Strategy Optimization: Maximize seller value through carve-outs, earn-outs, and retention incentives, with a track record of 20%+ premium realizations.
Let our advisors elevate your M&A journey—schedule a confidential consultation today.
